Structural variations in anchoring fibrils in dystrophic epidermolysis bullosa: correlation with type VII collagen expression.

Dystrophic epidermolysis bullosa is characterized by various abnormalities of anchoring fibrils, which are mainly composed of type VII collagen, at the dermal-epidermal junction. To define these changes more clearly, we examined skin samples from 22 patients with different forms of dystrophic epidermolysis bullosa by pre-embedding immunoelectron microscopy using an antibody (LH 7:2) that binds to the NC-1 globular domain of type VII collagen, followed by 1 nm colloidal gold-labeled secondary antibodies and subsequent silver enhancement. In dominant dystrophic epidermolysis bullosa cases, there was only a slight but variable reduction in the immunolabeling density on anchoring fibrils and on the lamina densa, in parts similar to normal human skin. In localized recessive dystrophic epidermolysis bullosa skin, some fibrillar structures just below the lamina densa (and particularly subjacent to hemidesmosomes) had specific antibody labeling despite their lack of resemblance to definitive anchoring fibrils. Immunolabeling with LH 7:2 was also seen within basal keratinocyte endoplasmic reticulum and cytoplasmic vesicles in some dystrophic epidermolysis bullosa patients, usually with milder phenotypic features. Even in the most severe cases of generalized recessive dystrophic epidermolysis bullosa, occasional immunolabeling was found within the lamina densa and on scanty thin filamentous structures at sub-lamina densa sites usually occupied by anchoring fibrils. This study suggests that dystrophic epidermolysis bullosa patients express some type VII collagen NC-1 domain epitopes that may be variably reduced at the dermal-epidermal junction or retained within basal keratinocytes. The clinical heterogeneity in dystrophic epidermolysis bullosa is mirrored by a range of immunoelectron microscopy findings, indicating variability in completeness of anchoring fibril formation and a possible spectrum of underlying type VII collagen structural protein abnormalities.

[1]  J. Uitto,et al.  Type VII collagen gene expression by cultured human cells and in fetal skin. Abundant mRNA and protein levels in epidermal keratinocytes. , 1992, The Journal of clinical investigation.

[2]  R. Briggaman,et al.  Epidermolysis bullosa dystrophica-recessive: a possible role of anchoring fibrils in the pathogenesis. , 1975, The Journal of investigative dermatology.

[3]  E. Bauer,et al.  Epidermolysis bullosa dystrophica , 1990 .

[4]  J. Uitto,et al.  Human type VII collagen: genetic linkage of the gene (COL7A1) on chromosome 3 to dominant dystrophic epidermolysis bullosa. , 1991, American journal of human genetics.

[5]  R. Eady,et al.  Evidence for a functional defect of the lamina lucida in recessive dystrophic epidermolysis bullosa demonstrated by suction blisters * , 1984, The British journal of dermatology.

[6]  I. Leigh,et al.  Intraepidermal type VII collagen. Evidence for abnormal intracytoplasmic processing of a major basement membrane protein in rare patients with dominant and possibly localized recessive forms of dystrophic epidermolysis bullosa. , 1990, Journal of the American Academy of Dermatology.

[7]  J. Ortonne,et al.  Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[8]  N. Morris,et al.  Type VII collagen forms an extended network of anchoring fibrils , 1987, The Journal of cell biology.

[9]  M Goossens,et al.  Genetic linkage of recessive dystrophic epidermolysis bullosa to the type VII collagen gene. , 1992, The Journal of clinical investigation.

[10]  R. Briggaman.  Is there any specificity to defects of anchoring fibrils in epidermolysis bullosa dystrophica, and what does this mean in terms of pathogenesis? , 1985, The Journal of investigative dermatology.

[11]  N. Morris,et al.  The Structure of Type VII Collagen a , 1985, Annals of the New York Academy of Sciences.

[12]  L. Bruckner-Tuderman,et al.  Epithelial-mesenchymal interactions enhance expression of collagen VII in vitro. , 1990, The Journal of investigative dermatology.

[13]  J. McGrath,et al.  Intracellular expression of type VII collagen during wound healing in severe recessive dystrophic epidermolysis bullosa and normal human skin , 1992, The British journal of dermatology.

[14]  S. Rüegger,et al.  Lack of type VII collagen in unaffected skin of patients with severe recessive dystrophic epidermolysis bullosa. , 1988, Dermatologica.

[15]  N. Morris,et al.  The tissue form of type VII collagen is an antiparallel dimer. , 1986, The Journal of biological chemistry.

[16]  R. Pearson.  Studies on the pathogenesis of epidermolysis bullosa. , 1962, The Journal of investigative dermatology.

[17]  E. Bauer,et al.  Human type VII collagen: cDNA cloning and chromosomal mapping of the gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Y. Barrandon,et al.  Epithelial origin of cutaneous anchoring fibrils , 1990, Journal of Cell Biology.

[19]  R. Eady,et al.  Ultrastructural morphometry of normal human dermal-epidermal junction. The influence of age, sex, and body region on laminar and nonlaminar components. , 1984, The Journal of investigative dermatology.

[20]  R. Briggaman,et al.  The carboxyl-terminal domain of type VII collagen is present at the basement membrane in recessive dystrophic epidermolysis bullosa. , 1989, The Journal of investigative dermatology.

[21]  C. Ramsay,et al.  Hereditary epidermolysis bullosa. , 1985, Journal of the American Academy of Dermatology.

[22]  R. Eady,et al.  DIAGNOSING EPIDERMOLYSIS BULLOSA , 1983, The British journal of dermatology.

[23]  J. Uitto.  Epidermolysis Bullosa: A Comprehensive Review of Classification, Management and Laboratory Studies , 1990 .

[24]  R. Glanville,et al.  Connective tissue microfibrils. Isolation and characterization of three large pepsin-resistant domains of fibrillin. , 1989, The Journal of biological chemistry.

[25]  Y. Okada,et al.  Increased gene expression of matrix metalloproteinase-3 (stromelysin) in skin fibroblasts from patients with severe recessive dystrophic epidermolysis bullosa. , 1991, Biochemical and biophysical research communications.

[26]  R. Eady,et al.  Evaluation of anchoring fibrils and other components of the dermal-epidermal junction in dystrophic epidermolysis bullosa by a quantitative ultrastructural technique. , 1985, The Journal of investigative dermatology.

[27]  J. Ortonne,et al.  Abnormal binding of an anti‐amnion antibody to epidermal basement membrane provides a novel diagnostic probe for junctional epidermolysis bullosa , 1985, The British journal of dermatology.

[28]  R. Burgeson.  Type VII Collagen , 1987 .

[29]  J. Seltzer,et al.  Cleavage of type VII collagen by interstitial collagenase and type IV collagenase (gelatinase) derived from human skin. , 1989, The Journal of biological chemistry.

[30]  E. Bauer,et al.  Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. , 1991, Journal of the American Academy of Dermatology.

[31]  R. Burgeson,et al.  Type VII collagen is a normal component of epidermal basement membrane, which shows altered expression in recessive dystrophic epidermolysis bullosa. , 1988, The Journal of investigative dermatology.

[32]  E. Engvall,et al.  Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils , 1986, The Journal of cell biology.

[33]  T. Reunala,et al.  Evidence for a structural abnormality of collagen VII in a patient with dystrophic epidermolysis bullosa inversa. , 1992, The Journal of investigative dermatology.

[34]  V. Sybert,et al.  Intra-epidermal retention of type VII collagen in a patient with recessive dystrophic epidermolysis bullosa. , 1990, The Journal of investigative dermatology.

[35]  J. Jester,et al.  Detection and partial characterization of a midlamina lucida-hemidesmosome-associated antigen (19-DEJ-1) present within human skin. , 1989, The Journal of investigative dermatology.

[36]  N. Morris,et al.  Type VII collagen is a major structural component of anchoring fibrils , 1986, The Journal of cell biology.

[37]  M. Farrall,et al.  Linkage of autosomal dominant dystrophic epidermolysis bullosa in three British families to the marker D3S2 close to the COL7A1 locus. , 1992, Journal of medical genetics.

[38]  J. Stanley,et al.  Epidermolysis bullosa acquisita antigen is synthesized by both human keratinocytes and human dermal fibroblasts. , 1985, The Journal of investigative dermatology.

[39]  I. Leigh,et al.  Identification of an epidermal basement membrane defect in recessive forms of dystrophic epidermolysis bullosa by LH 7:2 monoclonal antibody: use in diagnosis , 1986, The British journal of dermatology.

[40]  A. Eisen,et al.  The role of human skin collagenase in epidermolysis bullosa. , 1977, The Journal of investigative dermatology.